CRE Strategies Could Help Preserve Value in Life Sciences Mergers & Acquisitions
While pharmaceutical companies acquire sponsor-backed biotech companies, corporate real estate teams are becoming more responsible for preserving the value of those deals, according to a new CBRE insight. Even as acquired biotech firms tend to have smaller real estate footprints and leaner workforces, they become…
Subscription required
Read the full report at Connect CREPublished by Connect CRE. Global Real Estate Intelligence links to the original source and credits the publisher; all rights remain with them.
Provenance
- Publisher
- Connect CRE
- Obtained from
- Unknown: source not established
- Published
- Jul 17, 2026
- Last updated
- Jul 18, 2026 (1 month ago)
Global Real Estate Intelligence records where every item came from and when we last refreshed it. Where a field reads Unknown we could not establish it, and we do not guess.





